Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Factors that affect rate of INR decline after warfarin discontinuation.

Burmester JK, Berg RL, Schmelzer JR, Mazza JJ, Yale SH.

WMJ. 2015 Feb;114(1):16-20.

2.

Mirtazapine and mefloquine therapy for non-AIDS-related progressive multifocal leukoencephalopathy.

Epperla N, Medina-Flores R, Mazza JJ, Yale SH.

WMJ. 2014 Dec;113(6):242-5.

3.

A Cluster Randomized Trial of Interventions to Improve Work Conditions and Clinician Burnout in Primary Care: Results from the Healthy Work Place (HWP) Study.

Linzer M, Poplau S, Grossman E, Varkey A, Yale S, Williams E, Hicks L, Brown RL, Wallock J, Kohnhorst D, Barbouche M.

J Gen Intern Med. 2015 Feb 28. [Epub ahead of print]

PMID:
25724571
4.

Risk factors for recurrent spontaneous epistaxis.

Abrich V, Brozek A, Boyle TR, Chyou PH, Yale SH.

Mayo Clin Proc. 2014 Dec;89(12):1636-43. doi: 10.1016/j.mayocp.2014.09.009. Epub 2014 Nov 6.

PMID:
25458126
5.

Reinitiating Warfarin: Relationships Between Dose and Selected Patient, Clinical and Hospital Measures.

Leonhard LG, Berg RL, Burmester JK, Mazza JJ, Schmelzer JR, Yale SH.

Clin Med Res. 2014 Jun 4. pii: cmr.2014.1208. [Epub ahead of print]

6.

Drinking water systems, hydrology, and childhood gastrointestinal illness in Central and Northern Wisconsin.

Uejio CK, Yale SH, Malecki K, Borchardt MA, Anderson HA, Patz JA.

Am J Public Health. 2014 Apr;104(4):639-46. doi: 10.2105/AJPH.2013.301659. Epub 2014 Feb 13.

PMID:
24524509
7.

Association between blood glucose level and outcomes in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease.

Kasirye Y, Simpson M, Mamillapalli CK, Epperla N, Liang H, Yale SH.

WMJ. 2013 Dec;112(6):244-9; quiz 250.

8.

A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Kimmel SE, French B, Kasner SE, Johnson JA, Anderson JL, Gage BF, Rosenberg YD, Eby CS, Madigan RA, McBane RB, Abdel-Rahman SZ, Stevens SM, Yale S, Mohler ER 3rd, Fang MC, Shah V, Horenstein RB, Limdi NA, Muldowney JA 3rd, Gujral J, Delafontaine P, Desnick RJ, Ortel TL, Billett HH, Pendleton RC, Geller NL, Halperin JL, Goldhaber SZ, Caldwell MD, Califf RM, Ellenberg JH; COAG Investigators.

N Engl J Med. 2013 Dec 12;369(24):2283-93. doi: 10.1056/NEJMoa1310669. Epub 2013 Nov 19.

9.

Learning to predict post-hospitalization VTE risk from EHR data.

Kawaler E, Cobian A, Peissig P, Cross D, Yale S, Craven M.

AMIA Annu Symp Proc. 2012;2012:436-45. Epub 2012 Nov 3.

10.

Anti-phospholipid antibodies in patients undergoing total joint replacement surgery.

Simpson M, Sanfelippo MJ, Onitilo AA, Burmester JK, Hocking W, Yale SH, Mazza JJ.

Thrombosis. 2012;2012:142615. doi: 10.1155/2012/142615. Epub 2012 Oct 31.

11.

Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.

Sacco JC, Abouraya M, Motsinger-Reif A, Yale SH, McCarty CA, Trepanier LA.

Pharmacogenet Genomics. 2012 Oct;22(10):733-40. doi: 10.1097/FPC.0b013e328357a735.

12.

Spontaneous hemorrhage of a parathyroid adenoma into the mediastinum.

Huang J, Soskos A, Murad SM, Krawisz BR, Yale SH, Urquhart AC.

Endocr Pract. 2012 Jul-Aug;18(4):e57-60. doi: 10.4158/EP11329.CR.

13.

Azithromycin for bronchial asthma in adults: an effectiveness trial.

Hahn DL, Grasmick M, Hetzel S, Yale S; AZMATICS (AZithroMycin-Asthma Trial In Community Settings) Study Group.

J Am Board Fam Med. 2012 Jul-Aug;25(4):442-59. doi: 10.3122/jabfm.2012.04.110309.

14.

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group.

Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Erratum in: Am J Kidney Dis. 2012 Feb;59(2):318.

PMID:
21872376
15.

High prevalence of undetected vitamin D deficiency in an urban minority primary care practice.

Kahn LS, Satchidanand N, Kopparapu A, Goh W, Yale S, Fox CH.

J Natl Med Assoc. 2011 May;103(5):407-11.

PMID:
21809790
16.

The Emeritus Clinical-Researcher Program.

Yale S, Jones M, Wesbrook SD, Talsness S, Mazza JJ.

WMJ. 2011 Jun;110(3):127-31.

17.

Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses.

Burmester JK, Berg RL, Glurich I, Yale SH, Schmelzer JR, Caldwell MD.

Clin Med Res. 2011 Nov;9(3-4):119-24. doi: 10.3121/cmr.2011.951. Epub 2011 May 11.

18.
19.

The impact of serum glucose on clinical outcomes in patients hospitalized with community-acquired pneumonia.

Godar DA, Kumar DR, Schmelzer KM, Talsness SR, Liang H, Schmelzer JR, Mazza JJ, Yale SH.

WMJ. 2011 Feb;110(1):14-20.

20.

A randomized controlled trial of genotype-based Coumadin initiation.

Burmester JK, Berg RL, Yale SH, Rottscheit CM, Glurich IE, Schmelzer JR, Caldwell MD.

Genet Med. 2011 Jun;13(6):509-18. doi: 10.1097/GIM.0b013e31820ad77d.

PMID:
21423021
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk